Joseph P. Hagan

Insider Reports History

Location
San Diego, CA
Signature
/s/ Christopher Aker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph P. Hagan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aurinia Pharmaceuticals Inc. Director Common Stock 11,961 $134,681 $11.26 19 May 2023 Direct
Regulus Therapeutics Inc. Chief Executive Officer, Director Common Stock 0 $0 $7.87 25 Jun 2025 Direct
Regulus Therapeutics Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 1,350,000 30 Jan 2025 Direct
Zosano Pharma Corp Director Stock Option (Right to Buy) 30,000 10 Jun 2021 Direct
Zosano Pharma Corp Director Common Stock 22,500 10 Jun 2021 Direct
Aurinia Pharmaceuticals Inc. Director Restricted Stock Units 0 18 May 2023 Direct
Regulus Therapeutics Inc. Chief Executive Officer, Director Common Stock Purchase Warrant (Right to Buy) 0 25 Jun 2025 Direct
Regulus Therapeutics Inc. Chief Executive Officer, Director Stock Option 0 25 Jun 2025 Direct

Insider Reports Filed by Joseph P. Hagan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGLS Regulus Therapeutics Inc. 25 Jun 2025 13 $0 4 Chief Executive Officer, Director 27 Jun 2025, 17:05
RGLS Regulus Therapeutics Inc. 30 Jan 2025 2 +$54,260 4 Chief Executive Officer, Director 31 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 13 Jan 2025 2 -$160,495 4 Chief Executive Officer, Director 15 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 09 Jan 2025 2 +$378,100 4 Chief Executive Officer, Director 10 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 20 May 2024 1 $0 4 Chief Executive Officer, Director 21 May 2024, 16:21
RGLS Regulus Therapeutics Inc. 18 Jan 2024 1 -$17,359 4 Chief Executive Officer, Director 18 Jan 2024, 20:22
RGLS Regulus Therapeutics Inc. 12 Jan 2024 2 $0 4 Chief Executive Officer, Director 17 Jan 2024, 17:16
RGLS Regulus Therapeutics Inc. 10 Aug 2023 1 $0 4 President and CEO, Director 14 Aug 2023, 17:17
AUPH Aurinia Pharmaceuticals Inc. 18 May 2023 3 -$2,878 4 Director 23 May 2023, 17:18
RGLS Regulus Therapeutics Inc. 11 Jan 2023 1 $0 4 President and CEO, Director 17 Jan 2023, 15:11
AUPH Aurinia Pharmaceuticals Inc. 18 May 2022 2 $0 4 Director 20 May 2022, 16:07
RGLS Regulus Therapeutics Inc. 10 May 2022 1 $0 4 President and CEO, Director 11 May 2022, 16:54
RGLS Regulus Therapeutics Inc. 12 Jan 2022 2 +$21,520 4 President and CEO, Director 26 Jan 2022, 15:13
AUPH Aurinia Pharmaceuticals Inc. 03 Jan 2022 4 -$700,450 4 Director 04 Jan 2022, 15:17
AUPH Aurinia Pharmaceuticals Inc. 14 Jun 2021 1 $0 4 Director 16 Jun 2021, 21:23
/report/000156761921012083-hagan-joseph-p-2021-06-10 Zosano Pharma Corp 10 Jun 2021 2 $0 4 Director 14 Jun 2021, 20:31
RGLS Regulus Therapeutics Inc. 17 May 2021 1 -$3,726 4 President and CEO, Director 17 May 2021, 19:13